Effects of Home Based Step Aerobic Exercises

Sponsor
Afyonkarahisar Health Sciences University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05097196
Collaborator
(none)
10
1
1
8.7
1.2

Study Details

Study Description

Brief Summary

The aim of this study is to determine the effects of commercially produced new generation smart step board and step-aerobic exercises for 6 weeks on the functional capacity and physical performance of young sedentary individuals.

Condition or Disease Intervention/Treatment Phase
  • Other: Moderate-intensity aerobic activities
N/A

Detailed Description

The aim of this study is to determine the effects of commercially produced new generation smart step board and step-aerobic exercises for 6 weeks on the functional capacity and physical performance of young sedentary individuals. The primary outcomes to be evaluated are the functional improvements in individuals' balance, functional capacity, muscle strength, and resting heart rate after 6 weeks of step-aerobic exercises. Secondary results are the evaluation of the effects of individuals on jumping performance and exercise motivation. It is thought that the results obtained in the study will reveal new information for studies investigating home-based exercise and rehabilitation practices and may provide evidence for larger studies involving a diagnosis of a disease in the future.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
10 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Effects of Home Based Step Aerobic Exercises on the Functional Capacity and Physical Performance of Sedentary Young Adults: A Pilot Study
Actual Study Start Date :
Dec 30, 2021
Anticipated Primary Completion Date :
May 10, 2022
Anticipated Study Completion Date :
Sep 20, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Step Aerobic Group

Step aerobic exercise

Other: Moderate-intensity aerobic activities
The exercise intensity of the individual is planned at 50-60% heart rate reserve using the Karvonen method.

Outcome Measures

Primary Outcome Measures

  1. Functional capacity [10 weeks]

    Six minute walk test (6MWT) distance of the participants will be evaluated using the G-Walk sensor system

  2. Resting heart rate [10 weeks]

    Resting heart rate measurements are beats per minute taken in the morning

Secondary Outcome Measures

  1. Flamingo Balance Test [10 weeks]

    Static balances of the subjects will be determined with the Flamingo Balance Test.

  2. Quadriceps Strength [10 weeks]

    Testing will be done at 90 degrees of knee flexion using Mechanical Push/Pull Dynamometer (MPPD) 22 lb (Fabrication Enterprises Inc., USA).

  3. Counter movement jump [10 weeks]

    The jump parameters of the participants will be evaluated using the G-Walk sensor system (BTS G-Walk BTS Bioengineering Company, Italy).

  4. Exercise motivation [10 weeks]

    Motivation will be measured after exercise using a visual analog scale consisting of a 100 mm line. Individuals will mark on the line how motivated they are during exercise. Motivation points will be obtained by measuring the distance from zero to point o

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 25 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Not participating in an exercise program that is followed regularly for at least 6 months

  • Able to use a wearable device and willing to regularly step aerobic exercise

  • In possession of a smart phone, tablet or computer

  • BMI 25 to 40 kg/m2

Exclusion Criteria:
  • Severe concomitant diseases: chronic heart failure, liver cirrhosis, kidney failure, active cancer, and cardiovascular, orthopedic, neurological psychological other diseases

  • Not continuing the exercise program for more than three

  • Loss of balance due to loss of consciousness or dizziness in the last 6 months

Contacts and Locations

Locations

Site City State Country Postal Code
1 Afyonkarahisar Health Science University Afyonkarahisar Turkey

Sponsors and Collaborators

  • Afyonkarahisar Health Sciences University

Investigators

  • Principal Investigator: Yunus Emre Kundakci, PhD, Afyonkarahisar Health Sciences University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Yunus Emre Kundakçı, Lecturer, PhD, Afyonkarahisar Health Sciences University
ClinicalTrials.gov Identifier:
NCT05097196
Other Study ID Numbers:
  • 2021/439
First Posted:
Oct 28, 2021
Last Update Posted:
Apr 4, 2022
Last Verified:
Apr 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Yunus Emre Kundakçı, Lecturer, PhD, Afyonkarahisar Health Sciences University

Study Results

No Results Posted as of Apr 4, 2022